Successful nedaplatin desensitization therapy in a patient with platinum-sensitive recurrent ovarian cancer: A case report and literature review

•Platinum-based chemotherapy is the cornerstone of treatment for ovarian cancer.•Hypersensitivity reaction (HSR) is a serious adverse reaction of anticancer drugs with anaphylactic features.•HSR to platinum agents could lead to interruption of effective treatments for ovarian cancer, resulting in poor prognosis.•We presented a case of successful nedaplatin desensitization therapy with a history of HSR to carboplatin and nedaplatin.•The nedaplatin desensitization regimen could be an alternative for the patients with platinum sensitive ovarian cancer.